Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami

Joshua O. Cerasuolo, Manuel Montero-Odasso, Agustin Ibañez, Shannon Doocy, Gregory Y.H. Lip, Luciano A. Sposato

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

11 Citas (Scopus)


Atrial fibrillation affects 33.5 million people worldwide and its prevalence is expected to double by 2050 because of the aging population. Atrial fibrillation confers a 5-fold higher risk of ischemic stroke compared to sinus rhythm. We present our view of the role of shared medical decision-making to combat global underutilization of oral anticoagulation for stroke prevention in atrial fibrillation patients. Oral anticoagulation underuse is widespread as it is present within atrial fibrillation patients of all risk strata and in countries across all income levels. Reasons for oral anticoagulation underuse include but are probably not limited to poor risk stratification, over-interpretation of contraindications, and discordance between physician prescription preferences and actual administration. By comparing a catastrophic event to the consequences of atrial fibrillation related strokes, it may help physicians and patients understand the negative outcomes associated with oral anticoagulation under-utilization and the magnitude to which oral anticoagulations neutralize atrial fibrillation burden.

Idioma originalInglés
Páginas (desde-hasta)222-228
Número de páginas7
PublicaciónInternational Journal of Stroke
EstadoPublicada - 1 abr. 2017
Publicado de forma externa


Profundice en los temas de investigación de 'Decision-making interventions to stop the global atrial fibrillation-related stroke tsunami'. En conjunto forman una huella única.

Citar esto